# Dapsone

NDC: 0378-4830
Generic name: Dapsone
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GEL
Routes: TOPICAL
Marketing started: 20220520

FDA application: ANDA213847

## Active ingredients

- DAPSONE: 75 mg/g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-4830"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-4830
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e04da0a1-d02a-487d-a931-a31034738fdd